Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort StudyRon Ram, David Hagin, Ronen Ben‐Ami et al.|Transplantation and Cellular Therapy|2022Cited by 14